Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan L Stramer

Showing results (251-260 of 258) with videos related to

Pageof 26
Sort By:
You have reached the last page of results.This site can display upto 258 results.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Vox Sanguinis|April 12, 2019
International Forum on Occult hepatitis B infection and transfusion safetyClive R Seed, Jean-Pierre Allain, Miquel Lozano, et al.
Vox Sanguinis|March 1, 2019
International forum on Occult hepatitis B infection and transfusion safetyClive R Seed, Jean-Pierre Allain, Miquel Lozano, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Vox Sanguinis|March 22, 2024
An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NATHelen M Faddy, Carla Osiowy, Brian Custer, et al.
Vox Sanguinis|February 23, 2024
International review of blood donation nucleic acid amplification testingHelen M Faddy, Carla Osiowy, Brian Custer, et al.
Nature Biotechnology|August 29, 2020
Evaluation of SARS-CoV-2 serology assays reveals a range of test performanceJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Test performance evaluation of SARS-CoV-2 serological assaysJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Pageof 26

Showing results (251-260 of 258) with videos related to

Sort By:
Pageof 26
You have reached the last page of results.This site can display upto 258 results.
JAMA|September 2, 2021
Estimated US Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence Based on Blood Donations, July 2020-May 2021Jefferson M Jones, Mars Stone, Hasan Sulaeman, et al.
Vox Sanguinis|April 12, 2019
International Forum on Occult hepatitis B infection and transfusion safetyClive R Seed, Jean-Pierre Allain, Miquel Lozano, et al.
Vox Sanguinis|March 1, 2019
International forum on Occult hepatitis B infection and transfusion safetyClive R Seed, Jean-Pierre Allain, Miquel Lozano, et al.
Nature Communications|September 18, 2020
SARS-CoV-2 seroprevalence and neutralizing activity in donor and patient bloodDianna L Ng, Gregory M Goldgof, Brian R Shy, et al.
Vox Sanguinis|March 22, 2024
An international review of the characteristics of viral nucleic acid-amplification testing (NAT) reveals a trend towards the use of smaller pool sizes and individual donation NATHelen M Faddy, Carla Osiowy, Brian Custer, et al.
Vox Sanguinis|February 23, 2024
International review of blood donation nucleic acid amplification testingHelen M Faddy, Carla Osiowy, Brian Custer, et al.
Nature Biotechnology|August 29, 2020
Evaluation of SARS-CoV-2 serology assays reveals a range of test performanceJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Medrxiv : the Preprint Server for Health Sciences|June 9, 2020
Test performance evaluation of SARS-CoV-2 serological assaysJeffrey D Whitman, Joseph Hiatt, Cody T Mowery, et al.
Pageof 26